Shares of Biogen Inc. BIIB, -1.13% slid 2.98% to $220.04 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX, -0.45% falling 1.81% to 4,504.08 and Dow Jones Industrial Average DJIA, -0.17% falling 1.47% to 35,241.59. The stock’s fall snapped a two-day winning streak. Biogen Inc. closed $248.51 short of its 52-week high ($468.55), which the company reached on June 7th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson JNJ, -0.44% fell 1.21% to $169.42, Pfizer Inc. PFE, 0.09% fell 1.69% to $50.60, and AbbVie Inc. ABBV, -0.20% fell 0.34% to $142.71. Trading volume (1.3 M) remained 471,050 below its 50-day average volume of 1.8 M.